Cite Filings / FTH / 0001493152-26-008041

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Faeth Therapeutics, Inc. Filed 2026-02-25 Acc 0001493152-26-008041

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2026-02-25 SCHEDULE 13G Statement of Beneficial Ownership
2026-02-24 144 Sale of Securities
2026-02-19 4 Options or other derivatives
2026-02-19 3 Initial Statement of Ownership
2026-02-18 144 Sale of Securities
2026-02-18 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…